The first-ever ILD Day is happening on Wednesday, Sept. 15!

Working Together to Raise Awareness of Interstitial Lung Disease The first-ever ILD Day will take place on Wednesday, September 15, 2021 to drive awareness of interstitial lung disease (ILD). There are more than 200 types of interstitial lung disease, and more than 250,000 Americans are living with pulmonary fibrosis (PF) and ILD. Those with some…

Continue Reading

FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis

The U.S. Food and Drug Administration (FDA) has granted approval to Octapharma USA for Octagam® 10% the first and only intravenous immunoglobulin (IVIg) to be indicated for the treatment of adult dermatomyositis! The U.S. Food and Drug Administration (FDA) has granted approval to Octapharma USA for Octagam® 10% [Immune Globulin Intravenous (Human)], the first and only intravenous…

Continue Reading

TAP INTO THE POWER OF YOUR MIND

With the right intentions, you can use your mind as a tool to achieve amazing things.  You know how sometimes one rotten thing can ruin an otherwise wonderful day? What if you could stop that from happening, and stand up to the negativity that tries to interrupt your day? With mindfulness, you can. As a…

Continue Reading

TMA New Headquarters

In January 2021, we identified a need to address TMA’s occupancy and our desire to be the best stewards of the organization’s resources. In doing so, we found the Headquarters office in Alexandria, Virginia to be neither cost effective, or conducive to team collaboration in the way it was laid out. We set out on…

Continue Reading

DM Patient Opportunity

Are you an adult (18 years old or older) diagnosed with dermatomyositis (DM)? Modus Outcomes, a patient-centered outcomes research organization, is conducting 60-minute phone interviews with patients with DM to ask about their experience of DM. They can schedule the interview when it is convenient for you. They will ask you questions about your DM…

Continue Reading